Related Experiment Video
Updated: May 5, 2026

07:27
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
11.7K
Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian
Ying Li1, Xin Quan1, Yang Tai1
1Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
World Journal of Hepatology
|September 2, 2024
Summary
This study used Mendelian randomization to investigate immune cell phenotypes and liver cirrhosis, finding concrete causal links. These discoveries may guide new liver cirrhosis treatments.
Area of Science:
- Immunology
- Genetics
- Hepatology
Background:
- Liver cirrhosis is a progressive liver disease with growing interest in its immunological underpinnings.
- A clear causal link between immune cell phenotypes and liver cirrhosis remains to be established.
Purpose of the Study:
- To investigate the causal relationships between immunocyte phenotypes and liver cirrhosis using a Mendelian randomization (MR) approach.
Main Methods:
- Utilized genome-wide association study data for 731 immunocyte phenotypes.
- Employed a bidirectional two-sample MR study design with data from the FinnGen dataset (214,403 individuals).
- Inverse variable weighting was the primary analysis method, with sensitivity analyses for heterogeneity and pleiotropy.
Main Results:
- Identified 11 immunocyte phenotypes causally associated with increased liver cirrhosis risk (OR > 1).
- Found 9 immunocyte phenotypes causally associated with decreased liver cirrhosis risk (OR < 1).
- Confirmed bidirectional causal associations between liver cirrhosis and 19 distinct immune cell phenotypes, with no significant heterogeneity or pleiotropy.
Conclusions:
- Established concrete causal associations between specific immunocyte phenotypes and liver cirrhosis.
- Findings suggest novel therapeutic targets for liver cirrhosis treatment.
Related Concept Videos
Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42

